X4 Pharmaceuticals (XFOR) Assets (2018 - 2025)
X4 Pharmaceuticals (XFOR) has disclosed Assets for 8 consecutive years, with $163.6 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Assets fell 8.2% year-over-year to $163.6 million, compared with a TTM value of $163.6 million through Sep 2025, down 8.2%, and an annual FY2024 reading of $146.4 million, down 0.55% over the prior year.
- Assets was $163.6 million for Q3 2025 at X4 Pharmaceuticals, up from $105.2 million in the prior quarter.
- Across five years, Assets topped out at $210.6 million in Q2 2024 and bottomed at $81.0 million in Q2 2022.
- Average Assets over 5 years is $139.7 million, with a median of $141.7 million recorded in 2021.
- The sharpest move saw Assets soared 114.02% in 2023, then plummeted 50.07% in 2025.
- Year by year, Assets stood at $117.2 million in 2021, then surged by 32.78% to $155.6 million in 2022, then fell by 5.35% to $147.3 million in 2023, then fell by 0.55% to $146.4 million in 2024, then grew by 11.68% to $163.6 million in 2025.
- Business Quant data shows Assets for XFOR at $163.6 million in Q3 2025, $105.2 million in Q2 2025, and $130.0 million in Q1 2025.